Our program lasts a minimum of 3 months, on a subscription basis, where after 3 months, you can continue on as needed until you have achieved your health and weight loss goals and maintained them for 6-12 months. For more information, click here.
The rapid rise in popularity of semaglutide, GLP-1 medications, like Ozempic, Wegovy and Mounjaro, which were originally designed to treat type 2 diabetes, but are now approved as anti-obesity medications since 2021, is no surprise. These GLP-1 medications work to support weight loss in a number of ways such as:
Despite their effectiveness and the immense popularity of these medications, research has already shown that as soon as the medications are stopped, participants experience weight regain and metabolic dysfunction returns when nutritional and lifestyle interventions are absent.
There is no debate that successful, sustainable weight loss can be achieved with GLP-1 medications but ONLY in conjunction with sufficient nutritional and lifestyle interventions.